Anika Therapeutics (ANIK) Earnings (2010 - 2026)
Anika Therapeutics (ANIK) earnings from Jun 30, 2010 to Mar 31, 2026. The TTM Anika Therapeutics (ANIK) earnings is -$11M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Anika Therapeutics (ANIK) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -80.49% |
| 3 Years TTM | -20.78% |
| 5 Years TTM | -16.30% |
Annual Earnings change of Anika Therapeutics (ANIK)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$5.06M | -53.49% |
| 2025 | -$11M | -80.70% |
| 2024 | -$56M | -31.80% |
| 2023 | -$83M | +456.33% |
| 2022 | -$15M | -459.81% |
| 2021 | $4.13M | -117.22% |
| 2020 | -$24M | -188.19% |
| 2019 | $27M | +252.20% |
| 2018 | $7.72M | -75.74% |
| 2017 | $32M | -2.24% |
| 2016 | $33M | +5.82% |
| 2015 | $31M | -19.73% |
| 2014 | $38M | +86.20% |
| 2013 | $21M | +75.00% |
| 2012 | $12M | +38.84% |
| 2011 | $8.47M | +96.06% |
| 2010 | $4.32M | +17.07% |
| 2009 | $3.69M | N/A |
Comparison Anika Therapeutics (ANIK) five years earnings CAGR with competitors
Anika Therapeutics (ANIK) five years earnings CAGR is -16.30%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | -711.46% |
| TLRY | Tilray Brands Inc | 57.78% | -454.36% |
| PRGO | Perrigo Company plc | 51.08% | -413.31% |
| RGC | Regencell Bioscience Holdings Ltd | 34.56% | -312.00% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | -274.08% |
| UTHR | United Therapeutics Corp | 26.00% | -259.46% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -232.85% |
| AYTU | Aytu BioPharma Inc | 21.24% | -230.30% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -206.04% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -203.85% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -172.55% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -165.69% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -164.01% |
| ZTS | Zoetis Inc - Class A | 8.54% | -152.36% |
| KMDA | Kamada Ltd | 6.87% | -142.14% |
| PRFX | PRF Technologies Ltd | 6.09% | -137.34% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -130.83% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -123.00% |
| CPHI | China Pharma Holdings Inc | 3.58% | -121.97% |
| BHC | Bausch Health Companies Inc | 3.48% | -121.36% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -118.00% |